Accelrys Reports 4 Percent Uptick in Fiscal Q4 Revenues

The company said that its planned merger with Symyx has cleared the antitrust waiting period and is on track to close in early July.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.